Calendar

«« Feb 2008 »»
S M T W T F S
         
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 21 22 23
24 25 26 27 28 29

Search Box


HealthCentral Top Site Award

IBS Tales Hope Award

LinkBlog

[USA] Think Social Networks, Blogs Can’t Hurt You? Health insurers can use your on-line posts to avoid paying for treatment

Debunking the 'Chemical Imbalance' myth (pdf)

The Johns Hopkins Guide to Antidepressants (Note: requires registration of a valid email address)

Not Depressed, Just British!

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition

we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 1,234,669
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Webloogle Blog Directory

Bloggapedia - Find It!

Abstract: Glutamate modulators as novel interventions for mood disorders

« H E » email
posted Monday, 17 October 2005

Rev Bras Psiquiatr. 2005 Sep;27(3):243-248. Epub 2005 Oct 4.

Glutamate modulators as novel interventions for mood disorders.

Mathew SJ, Keegan K, Smith L.

Department of Psychiatry, Mount Sinai School of Medicine, New York, NY.

Recent evidence suggests that critical molecules in neurotrophic signaling cascades are long-term targets for currently available monoaminergic antidepressants. As chronic and severe mood disorders are characterized by impairments in neuronal resilience, pharmacological strategies that subserve a neuroprotective function might alter disorder pathophysiology and modify disease progression. Several promising approaches involve modulation of the glutamate neurotransmitter system, via post-synaptic receptor blockade or potentiation and presynaptic vesicular release inhibition.

A focused review of the extant scientific literature was conducted, with a discussion of 3 compounds or classes of drugs currently undergoing clinical investigation: ketamine, riluzole, and AMPA receptor potentiators.

Recent investigations in mood disordered patients suggest that the NMDA receptor antagonist ketamine might demonstrate rapid antidepressant properties. Riluzole has been shown to reverse glutamate-mediated impairments in neuronal plasticity and to stimulate the synthesis of brain derived neurotrophic factor. Open-label trials in treatment-resistant depression have yielded promising results. Likewise, AMPA receptor potentiators favorably impact neurotrophic factors as well as enhance cognition.

CONCLUSIONS: Pharmacological approaches that modulate components of the glutamate system offer novel targets for severe, recurrent mood disorders. Controlled studies are necessary.

PMID: 16224615 [PubMed - as supplied by publisher]


(Text has been reformatted for clarity; Ed.)


Source...

Full study text...


tags: clinical depression  ketamine  

links: digg this    del.icio.us    technorati    reddit